Healthcare -
Biotechnology - NASDAQ - US
$ 5.655
-1.82 %
$ 347 M
Market Cap
-3.18
P/E
GLUE - RESEARCH & DEVELOPMENT
Research & Development GLUE - Monte Rosa Therapeutics, Inc.
105 M
LAST VALUE
35.57%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR